Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19703885 | 0.76 | SMN1; SMN2 (0.38) | — | |
| SCHEMBL20414123 | 0.76 | SMN1; SMN2 (0.38) | — | |
| SCHEMBL26035877 | 0.76 | OPRK1 (0.33) | GLP1ROPRK1 | |
| SCHEMBL24658634 | 0.73 | CYP2C19 (0.33) | OPRK1 | |
| SCHEMBL26032070 | 0.71 | GLP1R (0.52) | GLP1ROPRK1 | |
| SCHEMBL26032035 | 0.71 | GLP1R (0.52) | GLP1ROPRK1 | |
| SCHEMBL26032037 | 0.71 | GLP1R (0.52) | GLP1ROPRK1 | |
| SCHEMBL26032096 | 0.71 | GLP1R (0.48) | GLP1ROPRK1 | |
| SCHEMBL19703449 | 0.71 | SMN1; SMN2 (0.37) | — | |
| SCHEMBL19703635 | 0.71 | SMN1; SMN2 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230226193-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS | Arrowhead Pharmaceuticals, Inc. | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230226193-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS | CPT1B, MUSK, MYLK2 | GLP1R 1985/4885OPRK1 2884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.